<html>
<head>PUBMED IDs for STK31</head>
<body bgcolor='#C5F0F2'><h1>STK31</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18246530/'>Characterization of a novel, testis-specific equine serine/threonine kinase.</a> February 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18281482/'>Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.</a> February 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/22828137/'>STK31 maintains the undifferentiated state of colon cancer cells.</a> January 18  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24755198/'>A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.</a> April 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25190507/'>Significance of serine threonine tyrosine kinase 1 as a drug resistance factor and therapeutic predictor in acute leukemia.</a> May 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27044426/'>Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.</a> December 15  2016<br></body></html>
